REGENERON PHARMACEUTICALS, INC. (REGN) Earnings Date & Options Risk
When REGN reports next, and what it means for options pricing. ← Full REGN risk overview
How REGN earnings affect options
REGENERON PHARMACEUTICALS, INC. (REGN) reports earnings on 2026-07-30, which falls inside a typical options expiry window. Earnings are the single biggest scheduled catalyst for an overnight gap: implied volatility usually runs up into the report and collapses immediately after (the IV crush). Selling premium into the event captures that crush but exposes you to the gap; buying premium needs a move large enough to beat the elevated IV you paid.
Scan REGN before earnings — free
See the full risk breakdown around REGN's earnings: IV vs HV, Expected Move, options flow and every other active catalyst.
Scan REGN Now →TickerRisk provides risk scoring for informational purposes only. Not financial advice. Options trading involves substantial risk of loss. Full disclaimer